IMLFF - InMed Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2780
+0.0280 (+11.20%)
As of 9:36AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.2500
Open0.2440
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2440 - 0.2800
52 Week Range0.2170 - 0.8200
Volume11,455
Avg. Volume278,398
Market Cap48.089M
Beta (3Y Monthly)3.18
PE Ratio (TTM)N/A
EPS (TTM)-0.0470
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • OTC Markets Group Launches OTCQX Cannabis Index
    PR Newswire15 days ago

    OTC Markets Group Launches OTCQX Cannabis Index

    NEW YORK , June 4, 2019 /PRNewswire/ --  OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...

  • CNW Grouplast month

    InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

    InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

  • InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019
    PR Newswirelast month

    InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019

    TSX:IN OTCQX:IMLFF VANCOUVER, BC , May 8, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary ...

  • InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology
    CNW Group3 months ago

    InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology

    OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as an R&D pipeline of medications targeting diseases with high unmet medical needs, today announced the publication of the first in a series of pending patent applications directed to the Company's biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids.

  • ACCESSWIRE3 months ago

    These Four Marijuana Stocks May Surge On Friday

    CORAL GABLES, FL / ACCESSWIRE / March 15, 2019 / The marijuana stock market is constantly evolving as a result of the world slowly gaining a better understanding of the benefits of supporting the global cannabis industry. According to recent statistics, the global legal marijuana market is projected to reach $146.4 billion by the end of 2025. Legal cannabis has gained traction on a global scale due to the fact that consumers are pushing legislators to advocate for legislation in support of marijuana legalization.

  • OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
    PR Newswire3 months ago

    OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

    OTCQX and OTCQB Companies Featured at 2019 ROTH Conference NEW YORK , March 13, 2019 /PRNewswire/ --  OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, ...

  • InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program
    CNW Group3 months ago

    InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program

    OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as a R&D pipeline of medications targeting diseases with high unmet medical needs, today provided an update on its drug development program for the treatment of Epidermolysis Bullosa ("EB").

  • PR Newswire3 months ago

    InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019

    OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as a R&D pipeline of medications targeting diseases with high unmet medical needs, today announced that InMed's President and Chief Executive Officer, Eric A. Adams, will be presenting on a panel discussion entitled "Cannabinoid Pharmaceuticals" at the 31st Annual ROTH Conference on Tuesday, March 19, 2019, at 10:00 AM PT, in Orange County, California.

  • CNW Group3 months ago

    InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board

    InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board

  • InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
    PR Newswire4 months ago

    InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

    TSX:IN OTCQX:IMLFF VANCOUVER , Feb. 12, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical ...

  • ACCESSWIRE4 months ago

    Watch These 4 Marijuana Stocks Push Their Limits on Monday (2/11/19)

    CORAL GABLES, FL / ACCESSWIRE / February 11, 2019 / The market surrounding marijuana stocks has continued to maintain a significant presence in media conversations when discussing future industries with the potential for exponential growth. Next Green Wave Holdings Inc (NXGWF) (NGW), KushCo Holdings Inc (KSHB), 1933 Industries Inc (TGIFF), and InMed Pharmaceuticals Inc (IMLFF) are 4 pot stocks making headlines this month. Next Green Wave Holdings Inc (NXGWF) (NGW) is a vertically integrated seed-to-consumer premium medicinal and recreational cannabis company operating in California, the world's largest cannabis market.

  • ACCESSWIRE4 months ago

    These Marijuana Stocks Should Be On Your Radar

    Although society has progressed much further in terms of recognizing the potential benefits of cannabis, there are still individuals who have yet to come to terms with the fact that more people are supportive of legalization. As a result of the recent passing of laws like the US Farm Bill, as well as Canada's country-wide legalization, individuals who would otherwise scoff at the cannabis industry, have now been brought into the fold due to the excitement surrounding the industry. Nabis Holdings (INNPF) (NAB), Amyris Inc (AMRS), InMed Pharmaceuticals Inc (IMLFF) (IN.TO), and Pyxus International Inc (PYX) are four cannabis companies working towards improving the quality of life for their consumers.

  • InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019
    PR Newswire4 months ago

    InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019

    TSX:IN OTCQX:IMLFF VANCOUVER , Feb. 5, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a fully integrated, cannabinoid-based biopharmaceutical ...

  • ACCESSWIRE5 months ago

    4 Marijuana Stocks Starting Strong On Friday (2/1/19)

    Following the recent passing of the U.S. Farm Bill, companies in the cannabis industry received the boost they needed from lawmakers to nudge consumers in the right direction, resulting in an increase in favorable public opinion. As we close out the month of January, Leafbuyer Technologies Inc (LBUY), The Supreme Cannabis Company Inc (SPRWF), InMed Pharmaceuticals Inc (IMLFF), and Aphria Inc (APHA) (APHA) are 4 pot stocks looking to set the pace on Friday. Leafbuyer Technologies Inc (LBUY) is one of the leading online resources for those in the cannabis industry.

  • ACCESSWIRE5 months ago

    4 Marijuana Stocks Looking To End January On High

    CORAL GABLES, FL / ACCESSWIRE / January 31, 2019 / Marijuana stocks have consistently managed to dominate headlines with news related to positive gains in the market, despite volatile conditions felt by other industries over the course of last year. As we close out the month of January, Leafbuyer Technologies Inc (OTC:LBUY), Aphria Inc (NYSE: APHA, TSX: APHA), Aurora Cannabis Inc (ACB), and InMed Pharmaceuticals Inc (IMLFF) are 4 pot stocks that are gaining tread on Thursday. ) is one of the leading online resources for those in the cannabis industry.

  • Benzinga5 months ago

    11 Company Pitches From Benzinga's Cannabis Capital Conference

    Benzinga's Cannabis Capital Conference brought major companies in the space face-to-face with investors in Miami Beach last week. The company is expecting to commence Phase 2 trials of EB treatment within six months. The company boasts a 60-percent reduction in costs for producer clients.

  • InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
    PR Newswire5 months ago

    InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer

    OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today announced that Dr. Sazzad Hossain, PhD, MSc, will assume a position as member of the Scientific Advisory Board ("SAB") and, contemporaneously, announced his retirement as Chief Scientific Officer ("CSO").  Dr. Eric C. Hsu, PhD, Vice President, Pre-Clinical Research & Development, will continue to lead the scientific R&D programs of the Company.